Category
-
Forbes
What Change Healthcare And The Postal Service Can Tell Us About The Coming Platform Revolution
March 28, 2024 -
Forbes
It’s Healthcare’s Data Era—Finally
March 27, 2024 -
PR Newswire
Capital Rx’s Enterprise Health Platform Enables Healthcare Organizations to Meet The CENTERS for MEDICARE & MEDICAID SERVICES’ M3P Requirements
March 27, 2024 -
Yahoo Finance
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
March 26, 2024 -
Yahoo Finance
Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology
March 26, 2024 -
BioCentury
Former BioMarin CEO Bienaimé named chair of Owkin
March 25, 2024 -
Owkin
Owkin expands collaboration with Sanofi leveraging AI for drug positioning in immunology
March 21, 2024 -
Fast Company
The World’s Most Innovative Companies of 2024
March 19, 2024 -
Business Wire
Almaden Genomics and Elucidata Pair g.nome® with Polly
March 19, 2024 -
BioSpace
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
March 19, 2024 -
The Economic Times
Engrail Therapeutics raises $157 million in funding from F-Prime Capital, others
March 19, 2024 -
Fast Company
This company is dispensing a dose of visibility into drug availability
March 19, 2024 -
Fierce Healthcare
Clover Health, Quartet Health team up against serious mental illness
March 19, 2024 -
Endpoints News
FDA greenlights Orchard’s gene therapy Lenmeldy for rare and fatal disease
March 18, 2024 -
Axios Pro
HiLabs inputs $39M for medical data cleanup
March 14, 2024 -
PR Newswire
Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance
March 13, 2024 -
PR Newswire
Doceree launches Spark to Ignite a New Era in Patient-Provider Engagement with Advanced Tech for EHR Platforms, at HIMSS 2024
March 12, 2024 -
Gearrice
Thanks to AI, this start-up wants to revolutionize pharmaceutical research
March 11, 2024 -
Biopharma Dive
NodThera says inflammation drug has positive effect in Parkinson’s
March 8, 2024 -
PR Newswire
OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
March 6, 2024 -
Endpoints News
Nocion Therapeutics Announces $62 Million Series B Financing to Advance Lead Program in Cough into Later Stage Development
March 4, 2024 -
AccessWire
Alcan Dental Cooperative Announces Strategic Partnership With CareStack to Enhance Dental Partnership Operations With Their Cloud-Based Dental Software Solutions
February 28, 2024 -
Goodwin
ARTBIO Collaborates with AlphaGen Therapeutics, and Enters into Three Strategic Agreements to Produce its Lead Asset AB001
February 28, 2024 -
Endpoints News
NodThera Touts Potential Weight Loss Effect of NLRP3 Inhibitors
February 20, 2024 -
ArtBio
AlphaGen Therapeutics and ARTBIO Announce Exclusive Strategic Collaboration for the Development and Commercialization of AB001 in Greater China and on ARTBIO’s 212Pb AlphaDirect™ Technology
February 20, 2024 -
PR Newswire
AppliedVR and Kernel Flow Announce Clinical Results Evaluating How Brain Changes During Virtual Reality Treatment of Chronic Pain
February 8, 2024 -
Medium
The New England Venture Capital Association Appoints Five New Directors, Kent Bennett to Board Chair
January 31, 2024 -
PR Newswire
Boston Scientific Receives FDA Approval for FARAPULSE™ Pulsed Field Ablation System
January 31, 2024 -
Yale University
Devoret and Schoelkopf win the Comstock Prize in Physics
January 23, 2024 -
Biomarker
F-Prime: Alex Pasteur, PhD
January 22, 2024 -
PR Newswire
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
January 18, 2024 -
Eleos Health
Eleos Health Grows Behavioral Health AI Product Offerings, Expands Reach to 25 States
January 17, 2024 -
Endpoints News
Comanche secures $75M to test preeclampsia siRNA in PhII, adds Scott Gottlieb to board
January 17, 2024 -
PR Newswire
ARTBIO and PharmaLogic Announce Supply Agreement for Lead-212 based Therapeutic Candidate AB001 for New York and Surrounding States
January 12, 2024 -
PR Newswire
OneAdvisory Rebrands as Dispatch, Closes $8 Million Seed Funding Round
January 11, 2024 -
Accesswire
1upHealth Reports 2023 as Record Year of Growth; Company Now Offers Largest Set of CMS APIs in the Industry
January 9, 2024 -
PR Newswire
Burro Closes $24 Million Series B Co-Led by Catalyst Investors and Translink Capital
January 9, 2024 -
Financial Times
UK start-up Genomics raises £35mn for advanced genetic testing
January 8, 2024 -
EQS News
Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates
January 8, 2024 -
PR Newswire
OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients
January 4, 2024 -
Fierce Healthcare
Devoted Health closes out 2023 with $175M series E funding round
January 1, 2024 -
Fierce Healthcare
VA deepens partnership with AppliedVR to expand access to immersive therapeutics
December 20, 2023 -
PR Newswire
Veterans Health Administration Extends Contract with AppliedVR to Continue Use of Virtual Reality for Treating Chronic Low Back Pain
December 20, 2023 -
Economic Times India
PlasmaGen Biosciences raises Rs 225 crore in equity funding
December 14, 2023 -
PR Newswire
WelbeHealth Opens First Bay Area PACE Center Serving Vulnerable Seniors in San Jose
December 12, 2023 -
PR Newswire
Fortune Announces the 2023 ‘Impact 20’ Startups That Are Making a Difference
December 12, 2023 -
Business Wire
Bicara Therapeutics Announces Oversubscribed $165 Million Series C Financing
December 12, 2023 -
Endpoints News
Exclusive: Shinobi raises $51M to take on cell therapy challenges with ex-Wugen CEO at helm, Carl June in support
December 12, 2023 -
Endpoints News
Biocon oncology spinout Bicara secures its second nine-figure financing of the year
December 12, 2023 -
Endpoints News
ARTBIO raises $90M as radiopharma field finds its footing
December 7, 2023 -
PR Newswire
ABK Biomedical announces that its Eye90 microspheres® device has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA)
December 5, 2023 -
PR Newswire
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD)
December 5, 2023 -
Oviva
A milestone in the digital health revolution: Doctors prescribe app-based obesity and diabetes care to 500,000th patient
December 4, 2023 -
PR Newswire
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
December 4, 2023 -
PR Newswire
AmplifyMD Named a Winner in Fast Company’s Next Big Things in Tech
November 30, 2023 -
PR Newswire
Eleos Health and Kipu Health Announce Partnership to Deliver AI-Powered Insights to Behavioral Health Providers
November 28, 2023 -
PR Newswire
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
November 15, 2023 -
The Standard
London doctors become first in the UK to ‘livestream’ surgery using robot
November 15, 2023 -
Financial Times
Biotech raises funds to find cancer treatments using transgenic mice
November 15, 2023 -
Globenewswire
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
November 15, 2023 -
PR Newswire
Capital Rx and Vida Health Partner to Launch Rx Activate, a High-Touch Chronic Condition Management Program
November 14, 2023 -
PR Newswire
NFlection Therapeutics Announces Positive Results from Phase 2b Study of NFX‑179 Topical Gel in the Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1
November 13, 2023 -
PR Newswire
Behavioral Health AI Leader Eleos Health Raises $40M Series B Round to Expand CareOps Automation Footprint
November 8, 2023 -
Endpoints News
AppliedVR is betting a new study could strengthen the case for insurance coverage of its VR chronic pain treatment
November 7, 2023 -
PR Newswire
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
November 6, 2023 -
Business Wire
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
November 6, 2023 -
Endpoints News
Prime Medicine showcases its first in vivo editing data in monkeys and mice
October 30, 2023 -
PR Newswire
ABK Biomedical Announces First Patient Treated in its Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma
October 24, 2023 -
Boston Business Journal
FDA lifts clinical hold on LDL-lowering drug from Verve Therapeutics
October 23, 2023 -
TechCrunch
Warmly pivots from Zoom tool to directing warm leads to sales
October 19, 2023 -
GlobeNewswire
NodThera announces first patients dosed in a Phase Ib/IIa cardiovascular risk trial of NLRP3 inflammasome inhibitor NT-0796
October 16, 2023 -
Business Wire
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
October 10, 2023 -
PR Newswire
Rippl and McLean Hospital collaborate to build ‘first of its kind’ dementia training program
October 9, 2023 -
PR Newswire
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
October 6, 2023 -
Globenewswire
Kyowa Kirin to Acquire Orchard Therapeutics
October 5, 2023 -
Business Wire
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
October 4, 2023 -
Globenewswire
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 -
PR Newswire
Doceree raises $35 million in Series B funding, led by Creaegis with participation from Eight Roads Ventures and F-Prime Capital
September 27, 2023 -
Endpoints News
Avalyn raises $175M to test inhaler versions of IPF medicines in PhII trials
September 27, 2023 -
Globenewswire
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
September 27, 2023 -
Endpoints News
Labcorp backs Adela’s $48M Series A1 to advance methylation-based head and neck cancer test
September 25, 2023 -
Nature
Peptone: finding opportunity in disorder
September 19, 2023 -
Wall Street Journal
All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say
September 19, 2023 -
Fierce Healthcare
Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients
September 19, 2023 -
Globenewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
September 14, 2023 -
Newswire
Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research
September 11, 2023 -
Globenewswire
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 5, 2023 -
Eleos Health
Eleos Health and KCare Join Forces to Improve Clinician Support with CareOps Automation
August 31, 2023 -
Boston Business Journal
Substance-use treatment startup Better Life Partners completes $26.5M Series B fundraise
August 29, 2023 -
PR Newswire
Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
August 28, 2023